Dr. Mayukh Banerjee is an environmental toxicologist whose career has been defined by a sustained commitment to uncovering the molecular mechanisms by which chronic arsenic exposure drives human disease, particularly skin carcinogenesis. Beginning with foundational training in zoology in India and a Ph.D. in Science from the Indian Institute of Chemical Biology, Dr. Banerjee’s early work integrated human genetics, toxicology, and population-based research to identify genetic markers of arsenic susceptibility. His subsequent postdoctoral training at the University of Alberta expanded this foundation, leading to the discovery and functional characterization of novel arsenic transport pathways mediated by the human multidrug resistance protein MRP4—work supported by the Alberta Cancer Foundation.

Since joining the University of Louisville in 2018 and transitioning to a tenure-track Assistant Professor role in 2020, Dr. Banerjee has established an independent research program that bridges toxicology, molecular biology, and carcinogenesis. His laboratory investigates how environmentally relevant arsenic exposure disrupts zinc-dependent proteins to alter crucial homeostatic processes including alternative splicing, mRNA methylation, proteostasis, and autophagy. This work has led to funded projects from the American Cancer Society, and Jewish Heritage Fund for Excellence, illuminating zinc displacement as a unifying mechanistic driver of arsenic-induced dysregulation.

Dr. Banerjee’s research productivity is reflected in numerous awards, invited talks, national presentations, and peer-reviewed publications. His contributions span mechanistic toxicology, risk assessment, biomarker discovery, and preventive strategies such as zinc supplementation, advancing both scientific understanding and public health approaches to mitigate the global burden of arsenic exposure and diseases thereof.